Prudential Financial’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $104K | Buy |
+12,410
| New | +$130K | ﹤0.01% | 2230 |
|
|
2025
Q3 | – | Sell |
-10,631
| Closed | -$87.3K | – | 2514 |
|
|
2025
Q2 | $87.3K | Buy |
+10,631
| New | +$89K | ﹤0.01% | 2299 |
|
|
2024
Q4 | – | Sell |
-48,769
| Closed | -$512K | – | 2606 |
|
|
2024
Q3 | $512K | Sell |
48,769
-2,600
| -5% | -$31.7K | ﹤0.01% | 2205 |
|
|
2024
Q2 | $601K | Buy |
51,369
+1,345
| +3% | +$20.9K | ﹤0.01% | 2090 |
|
|
2024
Q1 | $1.05M | Buy |
50,024
+2,880
| +6% | +$51.2K | ﹤0.01% | 1810 |
|
|
2023
Q4 | $846K | Sell |
47,144
-276
| -0.6% | -$4.86K | ﹤0.01% | 1910 |
|
|
2023
Q3 | $781K | Sell |
47,420
-21,250
| -31% | -$385K | ﹤0.01% | 1880 |
|
|
2023
Q2 | $1.37M | Sell |
68,670
-2,742
| -4% | -$52.8K | ﹤0.01% | 1641 |
|
|
2023
Q1 | $1.35M | Buy |
71,412
+800
| +1% | +$17.7K | ﹤0.01% | 1576 |
|
|
2022
Q4 | $1.6M | Buy |
70,612
+20,545
| +41% | +$464K | ﹤0.01% | 1439 |
|
|
2022
Q3 | $1.32M | Sell |
50,067
-40,285
| -45% | -$1.2M | ﹤0.01% | 1595 |
|
|
2022
Q2 | $2.23M | Buy |
90,352
+50,885
| +129% | +$1.27M | ﹤0.01% | 1337 |
|
|
2022
Q1 | $1.31M | Sell |
39,467
-3,014
| -7% | -$83.7K | ﹤0.01% | 1742 |
|
|
2021
Q4 | $1.39M | Buy |
42,481
+743
| +2% | +$25.3K | ﹤0.01% | 1724 |
|
|
2021
Q3 | $1.75M | Buy |
41,738
+2,739
| +7% | +$98.6K | ﹤0.01% | 1526 |
|
|
2021
Q2 | $1.51M | Sell |
38,999
-1,131
| -3% | -$40.5K | ﹤0.01% | 1617 |
|
|
2021
Q1 | $1.37M | Buy |
40,130
+5,710
| +17% | +$244K | ﹤0.01% | 1666 |
|
|
2020
Q4 | $1.56M | Sell |
34,420
-640
| -2% | -$22.4K | ﹤0.01% | 1540 |
|
|
2020
Q3 | $965K | Sell |
35,060
-2,680
| -7% | -$87.4K | ﹤0.01% | 1663 |
|
|
2020
Q2 | $1.39M | Sell |
37,740
-11,440
| -23% | -$426K | ﹤0.01% | 1500 |
|
|
2020
Q1 | $1.59M | Sell |
49,180
-1,864
| -4% | -$77.7K | ﹤0.01% | 1480 |
|
|
2019
Q4 | $2.09M | Sell |
51,044
-6,036
| -11% | -$238K | ﹤0.01% | 1580 |
|
|
2019
Q3 | $2.03M | Sell |
57,080
-57,060
| -50% | -$2.31M | ﹤0.01% | 1571 |
|
|
2019
Q2 | $5.86M | Buy |
114,140
+7,200
| +7% | +$359K | 0.01% | 1073 |
|
|
2019
Q1 | $6.13M | Sell |
106,940
-43,830
| -29% | -$2.17M | 0.01% | 1051 |
|
|
2018
Q4 | $6.32M | Buy |
150,770
+700
| +0.5% | +$41.1K | 0.01% | 993 |
|
|
2018
Q3 | $11.3M | Buy |
150,070
+4,310
| +3% | +$311K | 0.02% | 871 |
|
|
2018
Q2 | $10.5M | Buy |
145,760
+111,850
| +330% | +$5.34M | 0.02% | 907 |
|
|
2018
Q1 | $1.01M | Buy |
33,910
+10,560
| +45% | +$307K | ﹤0.01% | 1855 |
|
|
2017
Q4 | $776K | Buy |
+23,350
| New | +$703K | ﹤0.01% | 1909 |
|
Other funds holding RGNX
RG
VCM
IHAM
Prudential Financial's RGNX Position: Q1 2026 in Review
Prudential Financial opened a new position in Regenxbio (RGNX) in Q1 2026: 12,410 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #2230 among its holdings. This is a return to the name: Prudential Financial previously reported a position in RGNX as recently as Q2 2025.
Prudential Financial first reported a position in RGNX in Q4 2017 and has held it in 30 quarters since. The position peaked at $11.3M in Q3 2018. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- Prudential Financial held 12,410 shares of Regenxbio worth $104K as of Q1 2026.
- Regenxbio was a new Prudential Financial position in Q1 2026.
- Regenxbio made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2230 holding.
- Prudential Financial first reported a position in Regenxbio in Q4 2017 and has held it in 30 quarters since.
- Prudential Financial's Regenxbio position peaked at $11.3M in Q3 2018.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.